# TBC1D17

## Overview
TBC1D17 is a gene that encodes the protein TBC1 domain family member 17, which functions as a GTPase-activating protein (GAP). This protein is involved in the regulation of intracellular trafficking processes by modulating the activity of Rab GTPases, particularly Rab5 and Rab8. TBC1 domain family member 17 plays a critical role in endocytosis and vesicular trafficking, impacting processes such as glucose uptake and receptor recycling. The protein's activity is regulated through structural domains, including a TBC domain essential for its GAP function, and post-translational modifications like AMPK-mediated phosphorylation. Dysregulation of TBC1D17 has been linked to pathological conditions such as normal tension glaucoma and metabolic disorders, highlighting its significance in cellular homeostasis and potential as a therapeutic target (Rao2021AMPKmediated; Vaibhava2012Optineurin).

## Structure
TBC1D17 is a protein that contains several distinct domains contributing to its function as a GTPase-activating protein. The primary structure of TBC1D17 includes 648 amino acids, with specific regions identified for their roles in protein interactions and enzymatic activity. The TBC domain, spanning amino acids 310-520, is crucial for its GTPase-activating function, particularly in regulating Rab GTPases such as Rab5 and Rab8 (Rao2021AMPKmediated; Vaibhava2012Optineurin). 

The protein also features a proline-rich region at the C-terminus (amino acids 596-631) and an NHL repeat domain, both known for facilitating protein-protein interactions (Vaibhava2012Optineurin). The N-terminal region, encompassing amino acids 1-306, plays a role in auto-inhibition by interacting with the TBC domain, a process modulated by AMPK-mediated phosphorylation at Ser168 (Rao2021AMPKmediated).

Post-translational modifications, such as phosphorylation at Ser168, enhance the auto-inhibition of TBC1D17, affecting its interaction with Rab5 and its role in glucose uptake (Rao2021AMPKmediated). The structural configuration of TBC1D17, including its domain organization and post-translational modifications, underpins its regulatory functions in cellular processes.

## Function
TBC1D17 is a GTPase-activating protein (GAP) that plays a significant role in regulating intracellular trafficking processes in human cells. It primarily functions by modulating the activity of Rab GTPases, specifically Rab5 and Rab8, which are crucial for endocytosis and vesicular trafficking. TBC1D17 negatively regulates Rab5 by accelerating the hydrolysis of GTP to GDP, thereby converting Rab5 to its inactive form. This regulation is essential for controlling Rab5-mediated processes such as glucose uptake and Glut4 translocation, which are critical for maintaining glucose homeostasis in insulin-sensitive tissues like liver and skeletal muscle (Rao2021AMPKmediated).

TBC1D17 also interacts with Rab8, where it acts as a negative regulator by inactivating Rab8, thus affecting the trafficking and recycling of the transferrin receptor (TfR) to the plasma membrane. This interaction is facilitated by optineurin, which serves as an adaptor protein, enhancing the colocalization of TBC1D17 with Rab8. The inhibition of Rab8 by TBC1D17 is crucial for the regulation of endocytic trafficking processes (Vaibhava2012Optineurin).

Phosphorylation of TBC1D17 by AMPK at the Ser168 residue enhances its auto-inhibition, promoting Rab5 activation and facilitating glucose uptake, particularly during increased energy demands such as exercise (Rao2021AMPKmediated).

## Clinical Significance
Mutations and dysregulation of the TBC1D17 gene have been implicated in various pathological conditions. In the context of normal tension glaucoma, the E50K mutation in the OPTN gene leads to retinal cell death, a process mediated by TBC1D17. This mutation inhibits autophagy and transferrin receptor recycling, resulting in the accumulation of large autophagosomes and impaired cellular homeostasis, ultimately causing cell death. TBC1D17's catalytic activity is crucial for this process, and blocking its function can significantly prevent cell death, highlighting its potential clinical significance in glaucoma (Chalasani2014E50KOPTNInduced).

In metabolic contexts, TBC1D17 is involved in glucose uptake regulation. It acts as a GTPase-activating protein for Rab5, influencing Glut4 translocation and glucose uptake. AMPK-mediated phosphorylation of TBC1D17 enhances its auto-inhibition, promoting Rab5-dependent glucose uptake. Disruptions in TBC1D17 function could potentially affect glucose homeostasis, suggesting its relevance in conditions like insulin resistance and type 2 diabetes (Rao2021AMPKmediated). While the clinical significance of TBC1D17 mutations in these metabolic diseases is not fully established, its role in glucose metabolism indicates potential therapeutic targets.

## Interactions
TBC1D17 is a Rab GTPase-activating protein that interacts with several proteins to regulate various cellular processes. It interacts with optineurin, a Rab8-binding effector protein, to mediate the regulation of Rab8-mediated endocytic trafficking of the transferrin receptor (TfR). Optineurin facilitates the interaction and colocalization of TBC1D17 with Rab8, and a non-catalytic region of TBC1D17 is necessary for its direct interaction with optineurin (Vaibhava2012Optineurin). TBC1D17 acts as a GAP for Rab8, inactivating it by facilitating the hydrolysis of GTP to GDP, which inhibits Rab8's function in receptor recycling (Vaibhava2012Optineurin).

TBC1D17 also interacts with Rab5, another small GTPase involved in endocytosis. It preferentially binds to the GDP-loaded form of Rab5, indicating a regulatory role in Rab5's activity. The TBC domain of TBC1D17 is responsible for this interaction, while the N-terminal and C-terminal regions do not interact with Rab5 (Rao2021AMPKmediated). AMPK-mediated phosphorylation of TBC1D17 at the Ser168 residue enhances its auto-inhibition, promoting Rab5-dependent glucose uptake (Rao2021AMPKmediated). These interactions highlight TBC1D17's role in modulating the activity of Rab GTPases, influencing processes such as autophagy, receptor trafficking, and glucose uptake.


## References


[1. (Chalasani2014E50KOPTNInduced) Madhavi Latha Somaraju Chalasani, Asha Kumari, Vegesna Radha, and Ghanshyam Swarup. E50k-optn-induced retinal cell death involves the rab gtpase-activating protein, tbc1d17 mediated block in autophagy. PLoS ONE, 9(4):e95758, April 2014. URL: http://dx.doi.org/10.1371/journal.pone.0095758, doi:10.1371/journal.pone.0095758. This article has 51 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0095758)

[2. (Rao2021AMPKmediated) Xi Sheng Rao, Xiao Xia Cong, Xiu Kui Gao, Yin Pu Shi, Lin Jing Shi, Jian Feng Wang, Chen-Yao Ni, Ming Jie He, Yingke Xu, Cong Yi, Zhuo-Xian Meng, Jinling Liu, Peng Lin, Li Ling Zheng, and Yi Ting Zhou. Ampk-mediated phosphorylation enhances the auto-inhibition of tbc1d17 to promote rab5-dependent glucose uptake. Cell Death &amp; Differentiation, 28(12):3214â€“3234, May 2021. URL: http://dx.doi.org/10.1038/s41418-021-00809-9, doi:10.1038/s41418-021-00809-9. This article has 21 citations.](https://doi.org/10.1038/s41418-021-00809-9)

[3. (Vaibhava2012Optineurin) Vipul Vaibhava, Ananthamurthy Nagabhushana, Madhavi Latha Somaraju Chalasani, Cherukuri Sudhakar, Asha Kumari, and Ghanshyam Swarup. Optineurin mediates negative regulation of rab8 function by tbc1d17, a gtpase activating protein. Journal of Cell Science, January 2012. URL: http://dx.doi.org/10.1242/jcs.102327, doi:10.1242/jcs.102327. This article has 41 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1242/jcs.102327)